Note*: This report requires 7-10 business days to complete.
DelveInsight’s Herpes Zoster - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Herpes Zoster forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Herpes Zoster till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Herpes Zoster market.
• Identifying patient populations in the global “Herpes Zostermarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Herpes Zoster therapeutics in each of the markets covered.
• To understand the future market competition in the global Herpes Zoster therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Herpes Zoster for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Herpes Zoster overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Herpes Zoster Market
• Global Epidemiology of Herpes Zoster Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Herpes Zoster Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Herpes Zoster (2013-2023)
• Table 7: Herpes Zoster Global Market (USD Millions), (2013-2015)
• Table 8: Herpes Zoster Global Market (USD Millions), (2016-2023)
• Table 9: Herpes Zoster US Market (USD Millions), (2013-2015)
• Table 10: Herpes Zoster US Market (USD Millions), (2016-2023)
• Table 11: Herpes Zoster Germany Market (USD Millions), (2013-2015)
• Table 12: Herpes Zoster Germany Market (USD Millions), (2016-2023)
• Table 13: Herpes Zoster United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Herpes Zoster United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Herpes Zoster France Market (USD Millions), (2013-2015)
• Table 16: Herpes Zoster France Market (USD Millions), (2016-2023)
• Table 17: Herpes Zoster Italy Market (USD Millions), (2013-2015)
• Table 18: Herpes Zoster Italy Market (USD Millions), (2016-2023)
• Table 19: Herpes Zoster Spain Market (USD Millions), (2013-2015)
• Table 20: Herpes Zoster Spain Market (USD Millions), (2016-2023)
• Table 21: Herpes Zoster Japan Market (USD Millions), (2013-2015)
• Table 22: Herpes Zoster Japan Market (USD Millions), (2016-2023)
• Table 23: Herpes Zoster ROW Market (USD Millions), (2013-2015)
• Table 24: Herpes Zoster ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Herpes Zoster Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Herpes Zoster (2013-2023)
• Figure 3: Herpes Zoster Global Market (USD Millions), (2013-2015)
• Figure 4: Herpes Zoster Global Market (USD Millions), (2016-2023)
• Figure 5: Herpes Zoster US Market (USD Millions), (2013-2015)
• Figure 6: Herpes Zoster US Market (USD Millions), (2016-2023)
• Figure 7: Herpes Zoster Germany Market (USD Millions), (2013-2015)
• Figure 8: Herpes Zoster Germany Market (USD Millions), (2016-2023)
• Figure 9: Herpes Zoster United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Herpes Zoster United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Herpes Zoster France Market (USD Millions), (2013-2015)
• Figure 12: Herpes Zoster France Market (USD Millions), (2016-2023)
• Figure 13: Herpes Zoster Italy Market (USD Millions), (2013-2015)
• Figure 14: Herpes Zoster Italy Market (USD Millions), (2016-2023)
• Figure 15: Herpes Zoster Spain Market (USD Millions), (2013-2015)
• Figure 16: Herpes Zoster Spain Market (USD Millions), (2016-2023)
• Figure 17: Herpes Zoster Japan Market (USD Millions), (2013-2015)
• Figure 18: Herpes Zoster Japan Market (USD Millions), (2015-2023)
• Figure 19: Herpes Zoster ROW Market (USD Millions), (2013-2015)
• Figure 20: Herpes Zoster ROW Market (USD Millions), (2016-2023)
• Astellas Pharma Inc.
• Beijing Minhai Biotechnology Co. Ltd
• ContraVir Pharmaceuticals Inc.
• Epiphany Biosciences Inc.
• Foamix Pharmaceuticals Ltd.
• GeneOne Life Science Inc.
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• NAL Pharmaceuticals Ltd.
• ReceptoPharm Inc.
• TSRL Inc.
